Stromal cells in chronic inflammation and tertiary lymphoid organ formation

Annual Review of Immunology

Volumn 33, Issue , 2015, Pages 715-745

  Buckley, Christopher D ^a,b   Barone, Francesca ^a,b   Nayar, Saba ^a,b   Bénézech, Cecile ^b   Caamaño, Jorge ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Chronic inflammation; Fibroblast; Persistence; Stromal cells

Indexed keywords

CHEMOKINE;

ARTICLE; BLOOD ENDOTHELIUM; CELL ACTIVITY; CHRONIC DISEASE; CHRONIC INFLAMMATION; ENDOTHELIUM; FIBROBLAST; GENERAL ASPECTS OF DISEASE; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; LYMPH VESSEL ENDOTHELIUM; LYMPHOID ORGAN; LYMPHOID TISSUE; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; ANIMAL; CELL COMMUNICATION; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHENOTYPE;

ANIMALS; CELL COMMUNICATION; CHRONIC DISEASE; HUMANS; INFLAMMATION; LYMPHOID TISSUE; ORGANOGENESIS; PHENOTYPE; STROMAL CELLS;

EID: 84927645136     PISSN: 07320582     EISSN: 15453278     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-032713-120252     Document Type: Article

References (228)

1. Kuby J, ed. 1997. Immunology. New York:W.H. Freeman. 3rd ed.
2. Austyn JM, Wood KJ, eds. 1993. Principles of Cellular and Molecular Immunology. Oxford, UK: Oxford Univ. Press
3. Prati C, Demougeot C, Guillot X, Godfrin-Valnet M, Wendling D. 2014. Endothelial dysfunction in joint disease. Joint Bone Spine 81:386-91
4. Parsonage G, Filer AD, Haworth O, Nash GB, Rainger GE, et al. 2005. A stromal address code defined by fibroblasts. Trends Immunol. 26:150-56
5. Filer A, Raza K, Salmon M, BuckleyCD. 2008. The role of chemokines in leucocyte-stromal interactions in rheumatoid arthritis. Front. Biosci. 13:2674-85
6. Flavell SJ, Hou TZ, Lax S, Filer AD, Salmon M, et al. 2008. Fibroblasts as novel therapeutic targets in chronic inflammation. Br. J. Pharmacol. 153(Suppl. 1):S241-46
7. Greenbaum A, Hsu YM, Day RB, Schuettpelz LG, Christopher MJ, et al. 2013. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature 495:227-30
8. Aloisi F, Pujol-Borrell R. 2006. Lymphoid neogenesis in chronic inflammatory diseases. Nat. Rev. Immunol. 6:205-17
9. Klareskog L, Catrina AI, Paget S. 2009. Rheumatoid arthritis. Lancet 373:659-72
10. Bhowmick NA, Neilson EG, Moses HL. 2004. Stromal fibroblasts in cancer initiation and progression. Nature 432:332-37
11. ChangHY, Chi JT, Dudoit S,BondreC, van de Rijn M, et al. 2002. Diversity, topographic differentiation, and positional memory in human fibroblasts. PNAS 99:12877-82
12. Chang SK, Gu Z, Brenner MB. 2010. Fibroblast-like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin-11. Immunol. Rev. 233:256-66
13. Mor A, Abramson SB, Pillinger MH. 2005. The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clin. Immunol. 115:118-28
14. Buckley CD. 2003. Why do leucocytes accumulate within chronically inflamed joints? Rheumatology 42:1433-44
15. Firestein GS. 1996. Invasive fibroblast-like synoviocytes in rheumatoid arthritis: passive responders or transformed aggressors? Arthritis Rheum. 39:1781-90
16. Lee DM, Kiener HP, Agarwal SK, Noss EH, Watts GF, et al. 2007. Cadherin-11 in synovial lining formation and pathology in arthritis. Science 315:1006-10
17. Kalluri R, Zeisberg M. 2006. Fibroblasts in cancer. Nat. Rev. Cancer 6:392-401
18. Wilkinson LS, Pitsillides AA, Worrall JG, Edwards JC. 1992. Light microscopic characterization of the fibroblast-like synovial intimal cell (synoviocyte). Arthritis Rheum. 35:1179-84
19. Zimmermann T, Kunisch E, Pfeiffer R, Hirth A, Stahl HD, et al. 2001. Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture-primary culture cells markedly differ from fourth-passage cells. Arthritis Res. 3:72-76
20. Kiener HP, Niederreiter B, Lee DM, Jimenez-Boj E, Smolen JS, et al. 2009. Cadherin 11 promotes invasive behavior of fibroblast-like synoviocytes. Arthritis Rheum. 60:1305-10
21. Micke P, Ostman A. 2004. Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy? Lung Cancer 45(Suppl. 2):S163-75
22. Barsky SH, Green WR, Grotendorst GR, Liotta LA. 1984. Desmoplastic breast carcinoma as a source of human myofibroblasts. Am. J. Pathol. 115:329-33
23. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, et al. 2007. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449:557-63
24. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, et al. 2005. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121:335-48
25. Kraman M, Bambrough PJ, Arnold JN, Roberts EW, Magiera L, et al. 2010. Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-α. Science 330:827-30
26. Desmoulière A, Darby IA, Gabbiani G. 2003. Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab. Investig. 83:1689-707
27. Ho YY, Lagares D, Tager AM, Kapoor M. 2014. Fibrosis- A lethal component of systemic sclerosis. Nat. Rev. Rheumatol. 10:390-402
28. Wallach-Dayan SB, Golan-Gerstl R, Breuer R. 2007. Evasion of myofibroblasts from immune surveillance: a mechanism for tissue fibrosis. PNAS 104:20460-65
29. Filer A, Parsonage G, Smith E, Osborne C, Thomas AM, et al. 2006. Differential survival of leukocyte subsetsmediated by synovial, bonemarrow, and skin fibroblasts: site-specific versus activation-dependent survival of T cells and neutrophils. Arthritis Rheum. 54:2096-108
30. Parsonage G, Falciani F, Burman A, Filer A, Ross E, et al. 2003. Global gene expression profiles in fibroblasts from synovial, skin and lymphoid tissue reveals distinct cytokine and chemokine expression patterns. Thromb. Haemost. 90:688-97
31. Bradfield PF, Amft N, Vernon-Wilson E, Exley AE, Parsonage G, et al. 2003. Rheumatoid fibroblastlike synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8 +T cell migration within synovial tissue. Arthritis Rheum. 48:2472-82
32. Lally F, Smith E, Filer A, Stone MA, Shaw JS, et al. 2005. A novel mechanism of neutrophil recruitment in a coculture model of the rheumatoid synovium. Arthritis Rheum. 52:3460-69
33. McGettrick HM, Smith E, Filer A, Kissane S, Salmon M, et al. 2009. Fibroblasts from different sites may promote or inhibit recruitment of flowing lymphocytes by endothelial cells. Eur. J. Immunol. 39:113-25
34. Buckley CD, Filer A, Haworth O, Parsonage G, Salmon M. 2004. Defining a role for fibroblasts in the persistence of chronic inflammatory joint disease. Ann. Rheum. Dis. 63(Suppl. 2):ii92-95
35. LotzM, Terkeltaub R, Villiger PM. 1992. Cartilage and joint inflammation. Regulation of IL-8 expression by human articular chondrocytes. J. Immunol. 148:466-73
36. Koch AE,Kunkel SL, ShahMR, Fu R, Mazarakis DD, et al. 1995. Macrophage inflammatory protein-1β: a C-C chemokine in osteoarthritis. Clin. Immunol. Immunopathol. 77:307-14
37. Koch AE, Kunkel SL, Burrows JC, Evanoff HL, Haines GK, et al. 1991. Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. J. Immunol. 147:2187-95
38. Koch AE, Kunkel SL, Harlow LA, Mazarakis DD, Haines GK, et al. 1994. Macrophage inflammatory protein-1α: a novel chemotactic cytokine for macrophages in rheumatoid arthritis. J. Clin. Investig. 93:921-28
39. Nanki T, Shimaoka T, Hayashida K, Taniguchi K, Yonehara S, et al. 2005. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis. Arthritis Rheum. 52:3004-14
40. Patel DD, Zachariah JP, Whichard LP. 2001. CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. Clin. Immunol. 98:39-45
41. Burger JA, Zvaifler NJ, Tsukada N, Firestein GS, Kipps TJ. 2001. Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1-and CD106 (VCAM-1)-dependent mechanism. J. Clin. Investig. 107:305-15
42. Chan A, Filer A, Parsonage G, Kollnberger S, Gundle R, et al. 2008. Mediation of the proinflammatory cytokine response in rheumatoid arthritis and spondylarthritis by interactions between fibroblast-like synoviocytes and natural killer cells. Arthritis Rheum. 58:707-17
43. BombardieriM, Kam NW, Brentano F, Choi K, Filer A, et al. 2011. A BAFF/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells. Ann. Rheum. Dis. 70:1857-65
44. Bikker A, Kruize AA, WentingM, Versnel MA, Bijlsma JWJ, et al. 2012. Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjögren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity. Ann. Rheum. Dis. 71:1027-33
45. Ramos-Casals M. 2013. The B-lymphocyte stimulator connection in Sjögren's syndrome. Rheumatology 52:223-25
46. Muller-Ladner U, Gay S. 2002. MMPs and rheumatoid synovial fibroblasts: Siamese twins in joint destruction? Ann. Rheum. Dis. 61:957-59
47. Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, et al. 2000. Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum. 43:259-69
48. Muller-Ladner U, Kriegsmann J, Franklin BN,Matsumoto S, Geiler T, et al. 1996. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am. J. Pathol. 149:1607-15
49. Tolboom TC, van der Helm-Van Mil AHM, Nelissen RG, Breedveld FC, Toes RE, et al. 2005. Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis. Arthritis Rheum. 52:1999-2002
50. Lefèvre S, Knedla A, Tennie C, Kampmann A, Wunrau C, et al. 2009. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat. Med. 15:1414-20
51. Shigeyama Y, PapT,Kunzler P, Simmen BR, GayRE, et al. 2000. Expression of osteoclast differentiation factor in rheumatoid arthritis. Arthritis Rheum. 43:2523-30
52. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. 2006. Minimal criteria for definingmultipotentmesenchymal stromal cells.The International Society forCellular Therapy position statement. Cytotherapy 8:315-17
53. Haniffa MA, Collin MP, Buckley CD, Dazzi F. 2009. Mesenchymal stem cells: the fibroblasts' new clothes? Haematologica 94:258-63
54. SalemHK, ThiemermannC. 2010. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 28:585-96
55. Romieu-Mourez R, François M, Boivin MN, Bouchentouf M, Spaner DE, et al. 2009. Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. J. Immunol. 182:7963-73
56. Gonzalez MA, Gonzalez-Rey E, Rico L, Buscher D, Delgado M. 2009. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum. 60:1006-19
57. Schurgers E, Kelchtermans H, Mitera T, Geboes L, Matthys P. 2010. Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis. Arthritis Res. Ther. 12:R31
58. Buckner JH. 2010. Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases. Nat. Rev. Immunol. 10:849-59
59. Huggenberger R, Siddiqui SS, Brander D, Ullmann S, Zimmermann K, et al. 2011. An important role of lymphatic vessel activation in limiting acute inflammation. Blood 117:4667-78
60. Ulvmar MH,Werth K, Braun A, Kelay P, Hub E, et al. 2014. The atypical chemokine receptor CCRL1 shapes functional CCL21 gradients in lymph nodes. Nat. Immunol. 15:623-30
61. Osada M, Inoue O, Ding G, ShiraiT, IchiseH, et al. 2012. Platelet activation receptorCLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells. J. Biol. Chem. 287:22241-52
62. Watson SP, Lowe K, Finney BA. 2014. Platelets in lymph vessel development and integrity. Adv. Anat. Embryol. Cell Biol. 214:93-105
63. Liao S, Ruddle NH. 2006. Synchrony of high endothelial venules and lymphatic vessels revealed by immunization. J. Immunol. 177:3369-79
64. Pham TH, Baluk P, Xu Y,Grigorova I, Bankovich AJ, et al. 2010. Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning. J. Exp. Med. 207:17-27
65. Fletcher AL, Malhotra D, Turley SJ. 2011. Lymph node stroma broaden the peripheral tolerance paradigm. Trends Immunol. 32:12-18
66. Alitalo K. 2011. The lymphatic vasculature in disease. Nat. Med. 17:1371-80
67. Flister MJ, Wilber A, Hall KL, Iwata C, Miyazono K, et al. 2010. Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-κB and Prox1. Blood 115:418-29
68. Alitalo K, Tammela T, Petrova TV. 2005. Lymphangiogenesis in development and human disease. Nature 438:946-53
69. Kunder CA, St. John AL, Abraham SN. 2011. Mast cell modulation of the vascular and lymphatic endothelium. Blood 118:5383-93
70. Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, et al. 2004. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Investig. 113:1040-50
71. Hamrah P, Chen L, Zhang Q, Dana MR. 2003. Novel expression of vascular endothelial growth factor receptor (VEGFR)-3 and VEGF-C on corneal dendritic cells. Am. J. Pathol. 163:57-68
72. Mounzer RH, Svendsen OS, Baluk P, Bergman CM, Padera TP, et al. 2010. Lymphotoxin-alpha contributes to lymphangiogenesis. Blood 116:2173-82
73. Lee JY, Park C, Cho YP, Lee E, Kim H, et al. 2010. Podoplanin-expressing cells derived from bone marrow play a crucial role in postnatal lymphatic neovascularization. Circulation 122:1413-25
74. Kerjaschki D, Huttary N, Raab I, Regele H, Bojarski-Nagy K, et al. 2006. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat. Med. 12:230-34
75. Maruyama K, Ii M, Cursiefen C, Jackson DG, Keino H, et al. 2005. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J. Clin. Investig. 115:2363-72
76. Jamieson T, Cook DN, Nibbs RJ, Rot A, Nixon C, et al. 2005. The chemokine receptor D6 limits the inflammatory response in vivo. Nat. Immunol. 6:403-11
77. Podgrabinska S, Kamalu O, Mayer L, Shimaoka M, Snoeck H, et al. 2009. Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via Mac-1/ICAM-1-dependent mechanism. J. Immunol. 183:1767-79
78. Baluk P,Tammela T, Ator E, Lyubynska N, AchenMG, et al. 2005. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J. Clin. Investig. 115:247-57
79. von der Weid PY, Rehal S, Ferraz JG. 2011. Role of the lymphatic system in the pathogenesis of Crohn's disease. Curr. Opin. Gastroenterol. 27:335-41
80. Kajiya K, Detmar M. 2006. An important role of lymphatic vessels in the control of UVB-induced edema formation and inflammation. J. Investig. Dermatol. 126:919-21
81. Wilkinson LS, Edwards JC. 1991. Demonstration of lymphatics in human synovial tissue. Rheumatol. Int. 11:151-55
82. Thaunat O, Kerjaschki D, Nicoletti A. 2006. Is defective lymphatic drainage a trigger for lymphoid neogenesis? Trends Immunol. 27:441-45
83. Burman A, Haworth O, Hardie DL, Amft EN, Siewert C, et al. 2005. A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis. J. Immunol. 174:1693-700
84. Kerjaschki D, Regele HM, Moosberger I, Nagy-Bojarski K, Watschinger B, et al. 2004. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J. Am. Soc. Nephrol. 15:603-12
85. Karpanen T, Egeblad M, Karkkainen MJ, Kubo H, Yla-Herttuala S, et al. 2001. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res. 61:1786-90
86. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, et al. 2001. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7:192-98
87. Beasley NJ, Prevo R, Banerji S, Leek RD, Moore J, et al. 2002. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res. 62:1315-20
88. Kyzas PA, Geleff S, Batistatou A, Agnantis NJ, Stefanou D. 2005. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. J. Pathol. 206:170-77
89. Shields JD, Emmett MS,DunnDB, Joory KD, Sage LM, et al. 2007. Chemokine-mediated migration of melanoma cells towards lymphatics- A mechanism contributing to metastasis. Oncogene 26:2997-3005
90. Seeger H, Bonani M, Segerer S. 2012. The role of lymphatics in renal inflammation. Nephrol. Dial. Transplant. 27:2634-41
91. Pober JS, Sessa WC. 2007. Evolving functions of endothelial cells in inflammation. Nat. Rev. Immunol. 7:803-15
92. Clark PR, Manes TD, Pober JS, KlugerMS. 2007. Increased ICAM-1 expression causes endothelial cell leakiness, cytoskeletal reorganization and junctional alterations. J. Investig. Dermatol. 127:762-74
93. Adams DH, Shaw S. 1994. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 343:831-36
94. Meroni PL,KhamashtaMA,YouinouP, Shoenfeld Y. 1995. Mosaic of anti-endothelial antibodies: review of the first international workshop on anti-endothelial antibodies: clinical and pathological significance: Milan, 9 November 1994. Lupus 4:95-99
95. Hunt BJ, Jurd KM. 1998. Endothelial cell activation: a central pathophysiological process. BMJ 316:1328-29
96. Bierhaus A, Chevion S, Chevion M, Hofmann M, Quehenberger P, et al. 1997. Advanced glycation end product-induced activation of NF-κB is suppressed by α-lipoic acid in cultured endothelial cells. Diabetes 46:1481-90
97. Middleton J, Neil S, Wintle J, Clark-Lewis I,MooreH, et al. 1997. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91:385-95
98. Pober JS, Orosz CG, Rose ML, Savage CO. 1996. Can graft endothelial cells initiate a host anti-graft immune response? Transplantation 61:343-49
99. Shiao SL,McNiff JM, Pober JS. 2005. Memory T cells and their costimulators in human allograft injury. J. Immunol. 175:4886-96
100. Barone F, Bombardieri M, Manzo A, Blades MC, Morgan PR, et al. 2005. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome. Arthritis Rheum. 52:1773-84
101. Manzo A, Paoletti S, Carulli M, Blades MC, Barone F, et al. 2005. Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis. Eur. J. Immunol. 35:1347-59
102. Girard JP, SpringerTA. 1995. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol. Today 16:449-57
103. Carragher D, Johal R, Button A, White A, Eliopoulos A, et al. 2004. A stroma-derived defect in NF-κB2-/- mice causes impaired lymph node development and lymphocyte recruitment. J. Immunol. 173:2271-79
104. Browning JL, Allaire N, Ngam-ek A, Notidis E, Hunt J, et al. 2005. Lymphotoxin-βreceptor signaling is required for the homeostatic control of HEV differentiation and function. Immunity 23:539-50
105. Onder L, Danuser R, Scandella E, Firner S, Chai Q, et al. 2013. Endothelial cell-specific lymphotoxin-β receptor signaling is critical for lymph node and high endothelial venule formation. J. Exp. Med. 210:465-73
106. Costa C, Incio J, Soares R. 2007. Angiogenesis and chronic inflammation: cause or consequence? Angiogenesis 10:149-66
107. Helmlinger G, Yuan F, Dellian M, Jain RK. 1997. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med. 3:177-82
108. Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, et al. 2000. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res. 60:1388-93
109. Eliceiri BP, Cheresh DA. 1999. The role of αv integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J. Clin. Investig. 103:1227-30
110. Taylor PC, Sivakumar B. 2005. Hypoxia and angiogenesis in rheumatoid arthritis. Curr. Opin. Rheumatol. 17:293-98
111. Kim D, Mebius RE, MacMicking JD, Jung S, Cupedo T, et al. 2000. Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE. J. Exp. Med. 192:1467-78
112. DougallWC,GlaccumM,Charrier K, Rohrbach K, Brasel K, et al. 1999.RANKis essential for osteoclast and lymph node development. Genes Dev. 13:2412-24
113. Eberl G, Marmon S, Sunshine MJ, Rennert PD, Choi Y, et al. 2004. An essential function for the nuclear receptor RORγt in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5:64-73
114. Yokota Y, Mansouri A,Mori S, Sugawara S, Adachi S, et al. 1999. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397:702-6
115. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, et al. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-23
116. van de Pavert SA, Olivier BJ, Goverse G, Vondenhoff MF, Greuter M, et al. 2009. Chemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulation. Nat. Immunol. 10:1193-99
117. Luther SA, Ansel KM, Cyster JG. 2003. Overlapping roles of CXCL13, interleukin 7 receptor α, and CCR7 ligands in lymph node development. J. Exp. Med. 197:1191-98
118. Cupedo T, Kraal G, Mebius RE. 2002. The role of CD45+CD4+CD3- cells in lymphoid organ development. Immunol. Rev. 189:41-50
119. Cupedo T, Mebius RE. 2005. Cellular interactions in lymph node development. J. Immunol. 174:21-25
120. Naito A, Azuma S, Tanaka S, Miyazaki T, Takaki S, et al. 1999. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 4:353-62
121. Vondenhoff MF, Greuter M, Goverse G, Elewaut D, Dewint P, et al. 2009. LTβR signaling induces cytokine expression and up-regulates lymphangiogenic factors in lymph node anlagen. J. Immunol. 182:5439-45
122. Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, et al. 2002. The lymphotoxin-βreceptor induces different patterns of gene expression via two NF-κB pathways. Immunity 17:525-35
123. AnselKM, NgoVN, Hyman PL, Luther SA, ForsterR, et al. 2000.Achemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406:309-14
124. White A, Carragher D, Parnell S, Msaki A, Perkins N, et al. 2007. Lymphotoxin a-dependent and-independent signals regulate stromal organizer cell homeostasis during lymph node organogenesis. Blood 110:1950-59
125. Bénézech C, White A, Mader E, Serre K, Parnell S, et al. 2010. Ontogeny of stromal organizer cells during lymph node development. J. Immunol. 184:4521-30
126. Cupedo T, Vondenhoff MF, Heeregrave EJ, DeWeerd AE, Jansen W, et al. 2004. Presumptive lymph node organizers are differentially represented in developing mesenteric and peripheral nodes. J. Immunol. 173:2968-75
127. Bénézech C,Mader E, DesantiG, KhanM,Nakamura K, et al. 2012. Lymphotoxin-βreceptor signaling through NF-κB2-RelB pathway reprograms adipocyte precursors as lymph node stromal cells. Immunity 37:721-34
128. Ruddle NH, Akirav EM. 2009. Secondary lymphoid organs: responding to genetic and environmental cues in ontogeny and the immune response. J. Immunol. 183:2205-12
129. Roozendaal R, Mebius RE. 2011. Stromal cell-immune cell interactions. Annu. Rev. Immunol. 29:23-43
130. KatakaiT,HaraT, SugaiM,Gonda H, Shimizu A. 2004.Lymphnode fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes. J. Exp. Med. 200:783-95
131. Chai Q, Onder L, Scandella E, Gil-Cruz C, Perez-Shibayama C, et al. 2013. Maturation of lymph node fibroblastic reticular cells from myofibroblastic precursors is critical for antiviral immunity. Immunity 38:1013-24
132. Luther SA, Tang HL,Hyman PL, Farr AG, Cyster JG. 2000. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. PNAS 97:12694-99
133. Link A, Vogt TK, Favre S, BritschgiMR, Acha-Orbea H, et al. 2007. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat. Immunol. 8:1255-65
134. Cyster JG, AnselKM, Reif K, EklandEH, Hyman PL, et al. 2000. Follicular stromal cells and lymphocyte homing to follicles. Immunol. Rev. 176:181-93
135. Jarjour M, Jorquera A, Mondor I, Wienert S, Narang P, et al. 2014. Fate mapping reveals origin and dynamics of lymph node follicular dendritic cells. J. Exp. Med. 211:1109-22
136. Mionnet C, Mondor I, Jorquera A, Loosveld M, Maurizio J, et al. 2013. Identification of a new stromal cell type involved in the regulation of inflamed B cell follicles. PLOS Biol. 11:e1001672
137. Moussion C, Girard JP. 2011. Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules. Nature 479:542-46
138. WendlandM,Willenzon S, Kocks J,Davalos-Misslitz AC, Hammerschmidt SI, et al. 2011. Lymph node T cell homeostasis relies on steady state homing of dendritic cells. Immunity 35:945-57
139. Sixt M, Kanazawa N, Selg M, Samson T, Roos G, et al. 2005. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in theTcell area of the lymph node. Immunity 22:19-29
140. Bajenoff M, Germain RN. 2009. B-cell follicle development remodels the conduit system and allows soluble antigen delivery to follicular dendritic cells. Blood 114:4989-97
141. BajénoffM, Egen JG, Koo LY, Laugier JP, Brau F, et al. 2006. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 25:989-1001
142. Mueller SN, Germain RN. 2009. Stromal cell contributions to the homeostasis and functionality of the immune system. Nat. Rev. Immunol. 9:618-29
143. Roozendaal R, Mempel TR, Pitcher LA, Gonzalez SF, Verschoor A, et al. 2009. Conduits mediate transport of low-molecular-weight antigen to lymph node follicles. Immunity 30:264-76
144. Lochner M, Ohnmacht C, Presley L, Bruhns P, Si-Tahar M, et al. 2010. Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORγt and LTi cells. J. Exp. Med. 208:125-34
145. Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, et al. 2010. Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells. Nature 463:540-44
146. TsujiM, Suzuki K, Kitamura H,MaruyaM, Kinoshita K, et al. 2008. Requirement for lymphoid tissueinducer cells in isolated follicle formation and T cell-independent immunoglobulin A generation in the gut. Immunity 29:261-71
147. Rangel-Moreno J, Carragher DM, de la Luz Garcia-Hernandez M, Hwang JY, Kusser K, et al. 2011. The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat. Immunol. 12:639-46
148. Fukuyama S, Hiroi T, Yokota Y, Rennert PD, Yanagita M, et al. 2002. Initiation of NALT organogenesis is independent of the IL-7R, LTβR, and NIK signaling pathways but requires the Id2 gene and CD3-CD4+CD45+ cells. Immunity 17:31-40
149. Harmsen A, Kusser K, Hartson L, Tighe M, Sunshine MJ, et al. 2002. Cutting edge: organogenesis of nasal-associated lymphoid tissue (NALT) occurs independently of lymphotoxin-α (LTα) and retinoic acid receptor-related orphan receptor-γ, but the organization of NALT is LTαdependent. J. Immunol. 168:986-90
150. Nagatake T, Fukuyama S, Kim DY, Goda K, Igarashi O, et al. 2009. Id2-, RORγt-, and LTβRindependent initiation of lymphoid organogenesis in ocular immunity. J. Exp. Med. 206:2351-64
151. GeurtsvanKessel CH, Willart MA, Bergen IM, van Rijt LS, Muskens F, et al. 2009. Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J. Exp. Med. 206:2339-49
152. Fleige H, Ravens S, Moschovakis GL, Bolter J, Willenzon S, et al. 2014. IL-17-induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs. J. Exp. Med. 211:643-51
153. Moyron-Quiroz JE, Rangel-Moreno J, Kusser K, Hartson L, Sprague F, et al. 2004. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat. Med. 10:927-34
154. Rangel-Moreno J, Moyron-Quiroz JE, Carragher DM, Kusser K, Hartson L, et al. 2009. Omental milky spots develop in the absence of lymphoid tissue-inducer cells and support B and T cell responses to peritoneal antigens. Immunity 30:731-43
155. Carragher DM, Rangel-Moreno J, Randall TD. 2008. Ectopic lymphoid tissues and local immunity. Semin. Immunol. 20:26-42
156. Mittal S, RevellM, Barone F, Hardie DL, Matharu GS, et al. 2013. Lymphoid aggregates that resemble tertiary lymphoid organs define a specific pathological subset in metal-on-metal hip replacements. PLOS ONE 8:e63470
157. Neyt K, Perros F, GeurtsvanKessel CH, Hammad H, Lambrecht BN. 2012. Tertiary lymphoid organs in infection and autoimmunity. Trends Immunol. 33:297-305
158. Drayton DL, Liao S, Mounzer RH, Ruddle NH. 2006. Lymphoid organ development: from ontogeny to neogenesis. Nat. Immunol. 7:344-53
159. Aust G, Sittig D, Becherer L, Anderegg U, Schütz A, et al. 2004. The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases. Eur. J. Endocrinol. 150:225-34
160. Söderström N, Blörklund A. 1974. Organization of the invading lymphoid tissue in human lymphoid thyroiditis. Scand. J. Immunol. 3:295-301
161. Armengol MP, JuanM, Lucas-Martin A, Fernández-FiguerasMT, Jaraquemada D, et al. 2001. Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers. Am. J. Pathol. 159:861-73
162. Armengol MP, Cardoso-Schmidt CB, Fernández M, Ferrer X, Pujol-Borrell R, Juan M. 2003. Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in thyroid autoimmune diseases. J. Immunol. 170:6320-28
163. Drumea-MiranceaM,Wessels JT,MullerCA, Essl M, Eble JA, et al. 2006. Characterization of a conduit system containing laminin-5 in the human thymus: a potential transport system for small molecules. J. Cell Sci. 119:1396-405
164. Link A, Hardie DL, Favre S, Britschgi MR, Adams DH, et al. 2011. Association of T-zone reticular networks and conduits with ectopic lymphoid tissues in mice and humans. Am. J. Pathol. 178:1662-75
165. Takemura S, Braun A, Crowson C, Kurtin PJ, Cofield RH, et al. 2001. Lymphoid neogenesis in rheumatoid synovitis. J. Immunol. 167:1072-80
166. Rangel-Moreno J, Hartson L, Navarro C, Gaxiola M, Selman M, et al. 2006. Inducible bronchusassociated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J. Clin. Investig. 116:3183-94
167. AmftN,Curnow SJ, Scheel-Toellner D, Devadas A,Oates J, et al. 2001. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome. Arthritis Rheum. 44:2633-41
168. Hjelmstrom P, Fjell J, Nakagawa T, Sacca R, Cuff CA, et al. 2000. Lymphoid tissue homing chemokines are expressed in chronic inflammation. Am. J. Pathol. 156:1133-38
169. Hjelmstrom P. 2001. Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J. Leukoc. Biol. 69:331-39
170. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, et al. 2004. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J. Clin. Investig. 114:438-46
171. Weyand CM, Goronzy JJ. 2003. Ectopic germinal center formation in rheumatoid synovitis. Ann. N.Y. Acad. Sci. 987:140-49
172. Manzo A, Bombardieri M, Humby F, Pitzalis C. 2010. Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling. Immunol. Rev. 233:267-85
173. Salomonsson S, Larsson P, Tengnér P, Mellquist E, Hjelmstr öm P, Wahren-Herlenius M. 2002. Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome. Scand. J. Immunol. 55:336-42
174. Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik JP, Cylwik B, et al. 2003. Circulating tumour necrosis factor αand soluble tumour necrosis factor receptors in patients with different patterns of rheumatoid synovitis. Ann. Rheum. Dis. 62:472-75
175. Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik B, Skowronski J, et al. 2001. Serum cytokines in different histological variants of rheumatoid arthritis. J. Rheumatol. 28:1211-17
176. de Hair MJ, van de Sande MG, Ramwadhdoebe TH, Hansson M, Landewe R, et al. 2014. Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol. 66:513-22
177. Bugatti S, Manzo A, Benaglio F, Klersy C, Vitolo B, et al. 2012. Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs. Arthritis Res. Ther. 14:R34
178. Bugatti S, Caporali R, Manzo A, Vitolo B, Pitzalis C, et al. 2005. Involvement of subchondral bone marrow in rheumatoid arthritis: lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitment. Arthritis Rheum. 52:3448-59
179. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, et al. 1993. Regression of primary lowgrade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575-77
180. Barone F, Bombardieri M, Rosado MM, Morgan PR, Challacombe SJ, et al. 2008. CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjögren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization. J. Immunol. 180:5130-40
181. Xanthou G, Polihronis M, Tzioufas AG, Paikos S, Sideras P, et al. 2001. "Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients: possible participation in lymphoid structure formation. Arthritis Rheum. 44:408-18
182. Pitzalis C, Jones GW, Bombardieri M, Jones SA. 2014. Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat. Rev. Immunol. 14:447-62
183. Quartuccio L, Fabris M, Moretti M, Barone F, Bombardieri M, et al. 2008. Resistance to rituximab therapy and local BAFF overexpression in Sjögren's syndrome-related myoepithelial sialadenitis and low-grade parotid B-cell lymphoma. Open Rheumatol. J. 2:38-43
184. Kratz A,Campos-Neto A, Hanson MS,Ruddle NH. 1996. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J. Exp. Med. 183:1461-72
185. Picarella DE, Kratz A, Li CB, Ruddle NH, Flavell RA. 1993. Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice. J. Immunol. 150:4136-50
186. Sacca R, Kratz A, Campos-Neto A, Hanson MS, Ruddle NH. 1995. Lymphotoxin: from chronic inflammation to lymphoid organs. J. Inflamm. 47:81-84
187. DraytonDL, Ying X, Lee J,LesslauerW, Ruddle NH. 2003. EctopicLTαβdirects lymphoid organ neogenesis with concomitant expression of peripheral node addressin and aHEV-restricted sulfotransferase. J. Exp. Med. 197:1153-63
188. Luther SA, Lopez T, Bai W, Hanahan D, Cyster JG. 2000. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 12:471-81
189. Chen SC, Vassileva G, Kinsley D, Holzmann S,Manfra D, et al. 2002. Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J. Immunol. 168:1001-8
190. Fan L, Reilly CR, Luo Y, Dorf ME, Lo D. 2000. Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis. J. Immunol. 164:3955-59
191. Lira SA,Martin AP, Marinkovic T, Furtado GC. 2005. Mechanisms regulating lymphocytic infiltration of the thyroid in murine models of thyroiditis. Crit. Rev. Immunol. 25:251-62
192. FurtadoGC, Marinkovic T, Martin AP,Garin A, Hoch B, et al. 2007. Lymphotoxinβreceptor signaling is required for inflammatory lymphangiogenesis in the thyroid. PNAS 104:5026-31
193. Luther SA, Bidgol A, Hargreaves DC, Schmidt A, Xu Y, et al. 2002. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol. 169:424-33
194. Peters A, Pitcher LA, Sullivan JM, Mitsdoerffer M, Acton SE, et al. 2011. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity 35:986-96
195. Schrama D, thor Straten P, Fischer WH, McLellan AD, Brocker EB, et al. 2001. Targeting of lymphotoxin-αto the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue. Immunity 14:111-21
196. Yu P, Lee Y, Liu W, Chin RK, Wang J, et al. 2004. Priming of naive T cells inside tumors leads to eradication of established tumors. Nat. Immunol. 5:141-49
197. Astorri E, Bombardieri M, Gabba S, Peakman M, Pozzilli P, et al. 2010. Evolution of ectopic lymphoid neogenesis and in situ autoantibody production in autoimmune nonobese diabetic mice: cellular and molecular characterization of tertiary lymphoid structures in pancreatic islets. J. Immunol. 185:3359-68
198. Bombardieri M, Barone F, Humby F, Kelly S, McGurk M, et al. 2007. Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis andMALT lymphoma in Sjögren's syndrome. J. Immunol. 179:4929-38
199. Gräbner R, Lötzer K, Döpping S, Hildner M, Radke D, et al. 2009. Lymphotoxin βreceptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice. J. Exp. Med. 206:233-48
200. Lötzer K, Döpping S, Connert S, Gräbner R, Spanbroek R, et al. 2010. Mouse aorta smooth muscle cells differentiate into lymphoid tissue organizer-like cells on combined tumor necrosis factor receptor-1/lymphotoxin β-receptor NF-κB signaling. Arterioscler. Thromb. Vasc. Biol. 30:395-402
201. Wengner AM, Höpken UE, Petrow PK, Hartmann S, Schurigt U, et al. 2007. CXCR5-and CCR7-dependent lymphoid neogenesis in a murine model of chronic antigen-induced arthritis. Arthritis Rheumatol. 56:3271-83
202. Barone F, Nayar S, Buckley CD. 2012. The role of non-hematopoietic stromal cells in the persistence of inflammation. Front. Immunol. 3:416
203. Cupedo T, JansenW,Kraal G, Mebius RE. 2004. Induction of secondary and tertiary lymphoid structures in the skin. Immunity 21:655-67
204. Suematsu S, Watanabe T. 2004. Generation of a synthetic lymphoid tissue-like organoid in mice. Nat. Biotechnol. 22:1539-45
205. Peduto L, Dulauroy S, Lochner M, Spath GF, Morales MA, et al. 2009. Inflammation recapitulates the ontogeny of lymphoid stromal cells. J. Immunol. 182:5789-99
206. Krautler NJ, Kana V, Kranich J, Tian Y, Perera D, et al. 2012. Follicular dendritic cells emerge from ubiquitous perivascular precursors. Cell 150:194-206
207. Abe J, Shichino S, Ueha S, Hashimoto S, Tomura M, et al. 2014. Lymph node stromal cells negatively regulate antigen-specific CD4+ T cell responses. J. Immunol. 193:1636-44
208. Yang CY, Vogt TK, Favre S, Scarpellino L, Huang HY, et al. 2014. Trapping of naive lymphocytes triggers rapid growth and remodeling of the fibroblast network in reactive murine lymph nodes. PNAS 111:E109-18
209. Scandella E, Bolinger B, Lattmann E, Miller S, Favre S, et al. 2008. Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. Nat. Immunol. 9:667-75
210. Mueller SN, Matloubian M, Clemens DM, Sharpe AH, Freeman GJ, et al. 2007. Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection. PNAS 104:15430-35
211. Castagnaro L, Lenti E, Maruzzelli S, Spinardi L, Migliori E, et al. 2013. Nkx2-5+Islet1+ mesenchymal precursors generate distinct spleen stromal cell subsets and participate in restoring stromal network integrity. Immunity 38:782-91
212. Denton AE, Roberts EW, Linterman MA, Fearon DT. 2014. Fibroblastic reticular cells of the lymph node are required for retention of resting but not activated CD8+ T cells. PNAS 111:12139-44
213. Junt T, Scandella E, Ludewig B. 2008. Form follows function: lymphoid tissue microarchitecture in antimicrobial immune defence. Nat. Rev. Immunol. 8:764-75
214. Cremasco V, Woodruff MC, Onder L, Cupovic J, Nieves-Bonilla JM, et al. 2014. B cell homeostasis and follicle confines are governed by fibroblastic reticular cells. Nat. Immunol. 15:973-81
215. Gardner JM, Devoss JJ, Friedman RS, Wong DJ, Tan YX, et al. 2008. Deletional tolerance mediated by extrathymic Aire-expressing cells. Science 321:843-47
216. Lee JW, Epardaud M, Sun J, Becker JE, Cheng AC, et al. 2007. Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self. Nat. Immunol. 8:181-90
217. Fletcher AL, Lukacs-KornekV,Reynoso ED, Pinner SE, Bellemare-Pelletier A, et al. 2010. Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions. J. Exp. Med. 207:689-97
218. Dubrot J, Duraes FV, Potin L, Capotosti F, Brighouse D, et al. 2014. Lymph node stromal cells acquire peptide-MHCII complexes from dendritic cells and induce antigen-specific CD4+ T cell tolerance. J. Exp. Med. 211:1153-66
219. Baptista AP, Roozendaal R, Reijmers RM, Koning JJ, Unger WW, et al. 2014. Lymph node stromal cells constrain immunity via MHC class II self-antigen presentation. eLIFE 3:e04433
220. Lukacs-Kornek V, Malhotra D, Fletcher AL, Acton SE, Elpek KG, et al. 2011. Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes. Nat. Immunol. 12:1096-104
221. Siegert S, Huang HY, Yang CY, Scarpellino L, Carrie L, et al. 2011. Fibroblastic reticular cells from lymph nodes attenuate T cell expansion by producing nitric oxide. PLOS ONE 6:e27618
222. Khan O, Headley M, Gerard A, Wei W, Liu L, et al. 2011. Regulation of T cell priming by lymphoid stroma. PLOS ONE 6:e26138
223. Hammerschmidt SI, Ahrendt M, Bode U, Wahl B, Kremmer E, et al. 2008. Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo. J. Exp. Med. 205:2483-90
224. Molenaar R, GreuterM, van derMarel AP, Roozendaal R, Martin SF, et al. 2009. Lymph node stromal cells support dendritic cell-induced gut-homing of T cells. J. Immunol. 183:6395-402
225. Vicente-Suarez I, Larange A, Reardon C, Matho M, Feau S, et al. 2015. Unique lamina propria stromal cells imprint the functional phenotype of mucosal dendritic cells. Mucosal Immunol. 8:141-51
226. Iliev ID, Mileti E, Matteoli G, Chieppa M, Rescigno M. 2009. Intestinal epithelial cells promote colitisprotective regulatoryT-cell differentiation through dendritic cell conditioning. Mucosal Immunol. 2:340-50
227. Furtado GC, Pacer ME, Bongers G, Bénézech C, He Z, et al. 2014. TNFα-dependent development of lymphoid tissue in the absence of RORγt+ lymphoid tissue inducer cells. Mucosal Immunol. 7:602-14
228. Marinkovic T. 2006. Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid. J. Clin. Investig. 116:2622-32